Alamar Biosciences, Inc. | Finanzwire

Basculer en Français

9634	Companies
191588	Keywords
122999	Articles
102076	Press releases

Headlines Articles Press releases Alamar Biosciences, Inc.

Home
Companies
Alamar Biosciences, Inc.

BRIEF

published on 01/11/2026 at 22:25, 14 hours 16 minutes ago

Alamar Biosciences Secures $50 Million Through Oversubscribed Financing and Expands Leadership

Leadership Expansion Disease Detection Precision Proteomics Alamar Biosciences Convertible Notes Financing
PRESS RELEASE

published on 01/11/2026 at 22:20, 14 hours 21 minutes ago

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences closes oversubscribed convertible notes financing, welcomes new investors and expands leadership team with key appointments. T. Rowe Price and Braidwell LP join as investors. Dr. Stephen Williams appointed Chief Scientific Officer

Leadership Team New Investors Precision Proteomics Alamar Biosciences Convertible Notes Financing
BRIEF

published on 10/15/2025 at 15:20, 2 months 27 days ago

Alamar Biosciences Strengthens Leadership for Growth

Leadership Changes Financial Strategy Growth And Innovation Precision Proteomics Alamar Biosciences
PRESS RELEASE

published on 10/15/2025 at 15:15, 2 months 27 days ago

Alamar Biosciences Expands Executive Leadership to Power Next Phase of Growth
Alamar Biosciences expands executive leadership team with Tod White as President and Justin McAnear as CFO to drive growth and innovation in precision proteomics for disease detection

Executive Leadership Precision Proteomics Alamar Biosciences Tod White Justin McAnear
BRIEF

published on 10/09/2025 at 23:25, 3 months 2 days ago

Alamar Biosciences Unveils Innovative Blood-Based Assay for Alzheimer's Research

Alzheimer's Research Neurodegenerative Diseases Blood-based Assay Biomarker Detection Precision Proteomics
PRESS RELEASE

published on 10/09/2025 at 23:20, 3 months 2 days ago

Alamar Biosciences Launches NULISAqpcr™ BD-pTau217 Assay: A Breakthrough in Non-Invasive, Brain-Specific Biomarker Detection for Alzheimer's Disease Research
Alamar Biosciences launches NULISAqpcr™ BD-pTau217 Assay, a breakthrough in non-invasive, brain-specific biomarker detection for Alzheimer's disease research. The assay offers unparalleled sensitivity and CNS specificity, redefining biomarker quantitation

Alzheimer's Disease Biomarker Detection Precision Proteomics Alamar Biosciences NULISAqpcr BD-pTau217 Assay

Accesswire

Published on 01/12/2026 at 12:00, 41 minutes ago

NioCorp Provides Preliminary Unaudited Financial Results for the Three- and Six-Month Periods Ended December 31, 2025
Published on 01/12/2026 at 12:00, 41 minutes ago

Charlie's Holdings (OTCQB:CHUC) Signs Agreement with IKE Tech to Commercialize Transformational Age-Gated Vapes that Will Address FDA Concerns Related to Youth Access
Published on 01/12/2026 at 12:00, 41 minutes ago

Datavault AI Celebrates Successful Completion of Dream Bowl XIV, Pioneering Blockchain Innovation in Sports Entertainment
Published on 01/12/2026 at 11:30, 1 hour 11 minutes ago

FireFox Identifies Promising New Drill Targets at Mustajärvi Gold Project, Lapland, Finland
Published on 01/12/2026 at 09:01, 3 hours 40 minutes ago

Apex Secures Drill Contractor and Sets Planned Mobilization for Drilling at Rift

View all ACCESSWIRE

EQS Group

Published on 01/12/2026 at 12:15, 26 minutes ago

BIRKENSTOCK ANNOUNCES PRELIMINARY FISCAL FIRST QUARTER (ENDED DECEMBER 31, 2025) REVENUE OF €402 MILLION, GROWTH OF 17.8% IN CONSTANT CURRENCY; REPORT DATE AND CONFERENCE CALL
Published on 01/12/2026 at 12:05, 36 minutes ago

LEGO® Education Announces Hands-on Computer Science & AI Learning Solution
Published on 01/12/2026 at 11:30, 1 hour 11 minutes ago

Infosys and ATP Unveil 'Ally', an AI Chatbot to Elevate Fan Experience, and Announce Extension of Partnership Through 2028
Published on 01/12/2026 at 11:05, 1 hour 36 minutes ago

Windrose Consulting Group Expands Greater China and APAC Expertise with Acquisition of Zenith Access Network
Published on 01/12/2026 at 10:10, 2 hours 31 minutes ago

Personnel News: REPLOID Group AG expands Director-level leadership team

Les Echos

Published on 01/12/2026 at 09:00, 3 hours 41 minutes ago

Biophytis to Participate in the JP Morgan Healthcare Conference and the Biomed Forum
Published on 01/09/2026 at 18:30, 2 days 18 hours ago

H2 2025 half yearly report on the liquidity agreement signed with the Gilbert Dupont brokerage firm
Published on 01/09/2026 at 17:45, 2 days 18 hours ago

January 2026
Published on 01/09/2026 at 17:45, 2 days 18 hours ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 01/09/2026 at 17:42, 2 days 18 hours ago

Aéroports de Paris SA - Shares and voting rights as of 31 December 2025

View all LES ECHOS COMFI WIRE